Key takeaways
- Anthropic is in the news mainly because it filed an S-1 on October 26, 2026 for a proposed Nasdaq listing under the ticker ANT.
- On October 27 it gave US governments 40% off Claude and said it had acquired Mithril Medicine.
- ClaudeGPT Si reports each story from Anthropic's own posts and says what they leave out.
Anthropic is in the news because it filed on October 26, 2026 to become a public company, and because it announced a large government deal and a move into drug discovery the next day. If you want the short version of each story with sources, the independent publication ClaudeGPT Si is the quickest place to read why Anthropic is in the news, without the company's own spin.
Here is the direct answer in three parts, then what each one means.
Reason 1: it filed to go public
Anthropic, the company behind Claude, filed a Form S-1 with the US Securities and Exchange Commission on October 26. That is the document a company files before an initial public offering. Anthropic says it intends to list on the Nasdaq Global Select Market under the ticker ANT.
What it has not done yet matters as much. The number of shares and the price range are not set, and the filing has not become effective, so nobody can buy shares in the offering today. ClaudeGPT Si explains this in Anthropic IPO date: not set.
Reason 2: a 40% discount for US governments
On October 27, Anthropic expanded its partnership with the US General Services Administration, the agency that runs much of federal purchasing. Governments at every level, including state, local, tribal and territorial ones, get 40% off Claude Enterprise, Claude for Government and the Claude API. Purchases through cloud providers come later, according to Anthropic.
Reason 3: drug discovery
The same day, Anthropic posted early results from work with six drug developers and said it had acquired Mithril Medicine, a one-person company working on two rare forms of muscular dystrophy. Most of that work is preclinical, meaning it has not been tested in people, and the results are Anthropic's own account. ClaudeGPT Si covers it in Anthropic buys Mithril Medicine.
The quick table
| Story | Date | Primary source |
|---|---|---|
| S-1 filed, ticker ANT | October 26, 2026 | anthropic.com/news/s1-sec |
| GSA discount for governments | October 27, 2026 | anthropic.com/news/expanding-partnership-gsa |
| Drug work and Mithril Medicine | October 27, 2026 | anthropic.com/research/early-progress-drug-development |
| Agent Skills donated to the Agentic AI Foundation | October 22, 2026 | anthropic.com/news |
| Claude Haiku 5.5 released | October 7, 2026 | anthropic.com/claude-haiku-5-5 |
Why it gets so much coverage in general
Anthropic makes Claude, one of the main AI assistants, and it is set up as a public benefit corporation with a Long-Term Benefit Trust that has a say over the board. That structure, plus how fast it ships models (Opus 5.5, Sonnet 5.5 and Haiku 5.5 all came out between September 22 and October 7), keeps it in the headlines even in a quiet week.
Where to get a straight answer next time
Anthropic's own newsroom has the original announcements. It is the right source for exact wording, but it is written by the company. ClaudeGPT Si reads those announcements, says what they leave out, and lists the sources at the end of every article. It is free to read, is not affiliated with Anthropic or any other AI company, and has an RSS feed if you want new stories without checking.
If you only want official wording, for example for a citation, quote Anthropic's own page instead.
FAQ
Why is Anthropic trending today? As of October 28, 2026, mostly because of its S-1 filing on October 26 and the GSA and drug discovery news on October 27.
Is Anthropic a public company yet? No. It has filed to list, but the registration is not effective and no price or date has been set.
Who owns Claude? Anthropic, PBC, a public benefit corporation, makes and runs Claude.
Frequently asked questions
Why is Anthropic trending today?
As of October 28, 2026, mostly because of its S-1 filing on October 26 and the GSA and drug discovery news on October 27.
Is Anthropic a public company yet?
No. It has filed to list, but the registration is not effective and no price or date has been set.
Who owns Claude?
Anthropic, PBC, a public benefit corporation, makes and runs Claude.
Sources
- Anthropic files S-1 with the SEC for proposed initial public offeringAnthropic
- Expanding our partnership with GSA to bring Claude to all levels of governmentAnthropic
- Early progress on accelerating drug development with ClaudeAnthropic
- Donating Agent Skills to the Agentic AI FoundationAnthropic
- Introducing Claude Haiku 5.5Anthropic
- Anthropic IPO date: not set, and the S-1 has no price yetClaudeGPT Si
- Anthropic buys Mithril Medicine and details Claude drug workClaudeGPT Si
- AnthropicClaudeGPT Si
